- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06330519
Enhancing Anaesthetic Success in Mandibular Molars With Symptomatic Irreversible Pulpitis: A Comparative Randomized Controlled Trial
May 6, 2025 updated by: Ain Shams University
"Impact of Different Techniques on the Efficacy of Anaesthesia in Mandibular Molars With Acute Irreversible Pulpitis: A Randomized Controlled Trial"
The goal of this clinical trial is to assess the effect of
- Preoperative intraligamentary corticosteroids injection
Cryotherapy which is cold application on :
- Hard tooth structure ( crown of the tooth )
- Soft tissue overlying roots on the efficacy of the inferior alveolar nerve block anaesthesia in patients with mandibular molars with symptomatic irreversible pulpitis. The main question it aims to answer are: • Does intraligamentary dexamethazone injection increase the success rate of inferior alveolar nerve block without the need for oral premedication.
Participants will describe their preoperative pain level to the investigator and describe their pain level during the treatment.
Researchers will compare cryotherapy to see if it increases the success rate of inferior alveolar nerve block.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
188
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Ain shams university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participants willing to commit for the entire period of the trial and agreed to sign the written consent after full explanation of the study.
- Having a mandibular molar tooth diagnosed with symptomatic irreversible pulpitis (hot tooth - vital pulp, intermittent or continuous sharp pain that lasts longer after removal of the stimulus).
Exclusion Criteria:
- Presence of any systemic disease or allergic reactions.
- Vulnerable group; prisoners, pregnant females, mentally ill, etc…
- The presence of a periapical radiolucency.
- Teeth with open apices.
- A previous root canal treatment.
- Sinus tracts.
- Local gum swelling around the affected tooth.
- Severe periodontal disease .
- Presence of periodontal pockets >3 mm in the affected tooth.
- Absence of bleeding in the pulp chamber on access cavity preparation.
- Patients with doubted diagnosis due to multiple carious teeth.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intraligamentary dexamethazone
|
Patients receive 0.8ml of dexamethazone by periodontal ligament injection 30 minutes before the inferior alveolar nerve block
|
|
Active Comparator: Endo-ice cryotherapy
|
EndoIce (1,1,1,2 tetrafluoroethane) applied on the buccal, lingual (3 s/surface), and occlusal surfaces (4 s) for a total of 10 s then standard IANB was administered
Other Names:
|
|
Active Comparator: Intraoral soft tissue cryotherapy
|
Small ice packs (wrapped in sterile gauze) placed intraorally in the mouth on the vestibular surface of the treated tooth for 5 minutes then standard IANB was administered
|
|
No Intervention: Inferior Alveolar nerve block only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effect of intraligamentary dexamethazone injection on the success rate of inferior alveolar nerve block
Time Frame: Assessed up to 30 minutes, from lip numbness point until the end of pulp extirpation.
|
Percentage of the successful participants among total participants
|
Assessed up to 30 minutes, from lip numbness point until the end of pulp extirpation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Actual)
March 1, 2024
Study Completion (Actual)
March 30, 2024
Study Registration Dates
First Submitted
March 8, 2024
First Submitted That Met QC Criteria
March 19, 2024
First Posted (Actual)
March 26, 2024
Study Record Updates
Last Update Posted (Actual)
May 9, 2025
Last Update Submitted That Met QC Criteria
May 6, 2025
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Dental Pulp Diseases
- Tooth Diseases
- Pulpitis
- Antineoplastic Agents
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Inflammatory Agents
- Antiemetics
- Autonomic Agents
- Peripheral Nervous System Agents
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Protease Inhibitors
- Enzyme Inhibitors
- Anesthetics
- Central Nervous System Depressants
- Dexamethasone
- Dexamethasone acetate
- BB 1101
- Dexamethasone 21-phosphate
- Norflurane
Other Study ID Numbers
- Ainshams University Dentistry
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulpitis - Irreversible
-
Tehran University of Medical SciencesActive, not recruitingSymptomatic Irreversible Pulpitis (SIP) | Symptomatic Irreversible Pulpitis With Apical PeridontitisIran
-
Cairo UniversityNot yet recruitingPulpitis - Reversible | Pulpitis - Irreversible
-
Mansoura UniversityCompletedIrreversible Pulpitis | Reversible PulpitisEgypt
-
Urooj FatimaNot yet recruitingSymptomatic Irreversible Pulpitis | Irreversible Pulpitis | Asymptomatic Irreversible PulpitisPakistan
-
Jamia Millia IslamiaRecruiting
-
Cairo UniversityNot yet recruiting
-
Minia UniversityNot yet recruiting
-
Chulalongkorn UniversityNot yet recruiting
-
Sirawut Hiran-usChulalongkorn UniversityActive, not recruiting
-
College of Physicians and Surgeons PakistanActive, not recruiting
Clinical Trials on Dexamethasone sodium phosphate injection
-
Southeast University, ChinaNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)China
-
TheiaNova Ltd.Enrolling by invitation
-
Eye & ENT Hospital of Fudan UniversityShanghai Zhongshan Hospital; Shanghai Jiao Tong University Affiliated Sixth...Not yet recruiting
-
Semnur Pharmaceuticals, Inc.Cromos Pharma LLC; SyngeneNot yet recruitingLumbosacral Radicular Pain
-
Poznan University of Medical SciencesNot yet recruitingOsteoarthritis, Hip | Hip OsteoarthritisPoland
-
Ahmadu Bello University Teaching HospitalCompletedNeonatal Respiratory Distress SyndromeNigeria
-
Irfan ÜstündağCompletedPostoperative Pain Control | Postoperative Edema and Pain | Impacted Mandibular Third Molar ExtractionTurkey (Türkiye)
-
The Methodist Hospital Research InstituteRecruitingUreteral Stent-Related SymptomUnited States
-
University of TorontoWithdrawnRetinal DetachmentCanada
-
Sanliurfa Education and Research HospitalCompleted